logo
3M sees ‘strong' Q2 with $6.3B net sales

3M sees ‘strong' Q2 with $6.3B net sales

Yahoo22-07-2025
This story was originally published on Manufacturing Dive. To receive daily news and insights, subscribe to our free daily Manufacturing Dive newsletter.
Dive Brief:
3M saw its second quarter net sales increase 1.4% year over year to $6.3 billion, topping its expectations, according to the chemical and consumer goods manufacturer's earnings report last week.
By geography, China led the company's growth with strength in industrial adhesives, films and electronics bonding products. 3M's 'strong' delivery on its commercial plan drove growth, EVP and CFO Anurag Maheshwari said during the July 18 earnings call.
The company's 'strong operational improvement' prompted it to adjust its outlook upward, Maheshwari said. 3M upped its earnings per share guidance from $7.60 to $7.90 to between $7.75 and $8. The modified range now includes tariff impacts as well, according to a Q2 presentation.
Dive Insight:
3M previously did not factor tariffs into its guidance due to the situation's uncertainty, Maheshwari said. But the company decided to include tariff impacts in its guidance for the second half of 2025 as conditions evolve.
Additionally, the company is more than halfway through the year, 'and any changes from here, we'd only have a couple of months in the balance of the year that would impact '25,' Chairman and CEO William Brown said during the earnings call. 'The rest would roll into 2026. So we feel we're pretty well calibrated.'
Brown noted that the tariff rates have decreased to a cumulative 30% after the United States and China agreed in May to de-escalate their trade war for 90 days. The previous rate increased to 145% and 3M initially expected to incur $850 million in tariff-related expenses this year. The Scotch tape maker began planning and adjusting its product sourcing and logistics last quarter to mitigate the tariff burden.
Still, the 30% rate may change. China and the U.S. have reached a proposed agreement under which the U.S. would impose 55% tariffs on Chinese imports, and China would impose 10% tariffs on U.S. imports. Though as of July 22, the deal has yet to be finalized.
While things have stabilized at least somewhat, 3M is keeping a close eye on the European Union's trade negotiations, as well as any potential re-escalation and trade tensions with China, Brown said.
'From the way we see it today, I think we know enough about it in terms of the gross and net impact to roll it through into guidance, which I think is cleaner for investors,' the CEO added.
Looking ahead to the second half of 2025, 3M will continue to invest in its growth initiatives as it navigates the unpredictable economic climate, including the launch of new products, Brown said. In February, 3M announced it will spend $3.5 billion on research and development from 2025 to 2027 as part of its goal to launch 1,000 products over the next three years. The consumer product maker's efforts include moving away from PFAS in its manufacturing processes and product development, as the company is on track to end the use of these toxic substances by 2026.
In Q2, 3M launched 64 new products, up 70% YoY, Brown said. The new products in H1 total 126, putting 3M on track to exceed its target of 215 new products this year.
The company expects to see improvements in growth from product innovation and margin, Brown said.
'But really, what we're focused on is delivering against customer expectations, beating the competition, regaining share of wallet and just getting back to that spirit of innovation at the company,' the CEO said.
While things are looking up for 3M, the manufacturing giant is working through several lawsuits that accused it of PFAS contamination over the last few decades. In May, 3M reached a proposed agreement with the New Jersey Department of Environmental Protection to pay up to $450 million to resolve all legacy PFAS-related claims in the state. The deal is awaiting a judge's approval.
While 3M began issuing payments to public water suppliers that opt in to receive the $10.5 billion settlement, the manufacturer still faces several cases from state attorneys general, according to its securities filing. Some of the cases are associated with the multidistrict litigation involving aqueous film-forming foam.
3M, along with other chemical titans such as DuPont de Nemours and Chemours Co., are slated to have a court date on Oct. 20 for the first bellwether personal injury trial, according to the filing. The plaintiffs are accusing the companies of causing kidney cancer due to their PFAS usage. The court has directed all parties to negotiate and reach a settlement ahead of the trial.
'We're managing as best that we can,' Brown said. 'It's important for us to make sure that we maintain the cash flexibility to handle these issues as they come, yet still invest in the growth of the company. And that's what we're trying to do.'
Recommended Reading
3M expects up to $850M tariff hit
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Asian Stocks Set for Subdued Open Ahead of Fed: Markets Wrap
Asian Stocks Set for Subdued Open Ahead of Fed: Markets Wrap

Bloomberg

time24 minutes ago

  • Bloomberg

Asian Stocks Set for Subdued Open Ahead of Fed: Markets Wrap

Asian equities are set for a lackluster start ahead of the Federal Reserve's policy decision, with investors showing little enthusiasm for progress in US-China trade talks. Futures for Tokyo and Hong Kong equities pointed lower, while Sydney contracts were flat after the S&P 500 snapped a six-day rally, slipping 0.3%. Treasuries climbed, led by longer-dated notes, following a solid $44 billion sale. Oil held gains early Wednesday after President Donald Trump's reiteration that further levies on Russia remained on the table without a Ukraine truce.

Trump to Get Last Word on China Truce Extension, Bessent Says
Trump to Get Last Word on China Truce Extension, Bessent Says

Bloomberg

timean hour ago

  • Bloomberg

Trump to Get Last Word on China Truce Extension, Bessent Says

By and Rainier Harris Save Good morning. The US and China aren't done talking. Trump gives Russia 10 days to reach a Ukraine truce. And a mass shooting in Manhattan evokes grief and prompts tighter security. Listen to the day's top stories. The third round of US-China trade talks wrapped up without clarity on the fate of the tariff truce that's set to expire in two weeks. China's delegation earlier said a 90-day extension had been reached, but Treasury Secretary Scott Bessent said they 'jumped the gun a little' and that Donald Trump will make the final call. The president, returning from Scotland after dealing the EU a harsh blow in the trade war, said India may face a tariff rate of 20% to 25%.

AstraZeneca's US Investment, Future of Psychedelic Therapy
AstraZeneca's US Investment, Future of Psychedelic Therapy

Bloomberg

timean hour ago

  • Bloomberg

AstraZeneca's US Investment, Future of Psychedelic Therapy

On today's episode of Bloomberg Businessweek Daily with Tim Stenovec and Carol Massar, Pascal Soriot, Chief Executive Officer of AstraZeneca discusses the company's quarterly earnings. Kabir Nath, Chief Executive Officer of Compass Pathways, on the pursuit of FDA approval of the first psychedelic treatment for certain people living with depression. Also, Bloomberg's Molly Smith and Oliver Crook on US-China Trade talks and the FOMC meeting (Source: Bloomberg)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store